Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH1251125998
Thu, 10.04.2025
Relief Therapeutics Holding SA
Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update
GENEVA (APR. 10, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its 2024 Annual Report an [ … ]
Thu, 06.03.2025
Relief Therapeutics Holding SA
Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion
GENEVA (March 6, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that discussi [ … ]
Wed, 22.01.2025
Relief Therapeutics Holding SA
Relief Therapeutics Completes Strategic Transition with Sale of GOLIKE® Rights ex-USSale of GOLIKE® Rights Outside the U.S. to Nutrisens
Relief to Focus on R&D of Pipeline Assets and Licensing for Commercialized Products
GENEVA (JAN. 22, 2025) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharm [ … ]